Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19876078 | 0.95 | SMN1; SMN2 (0.56) | ALDH1A1TDP1SMN1; SMN2TSHRTP53 | |
| SCHEMBL28156462 | 0.87 | SMN1; SMN2 (0.49) | ALDH1A1TDP1SMN1; SMN2TSHRTP53 | |
| SCHEMBL28337546 | 0.83 | LMNA (0.55) | ALDH1A1TDP1SMN1; SMN2TSHR | |
| SCHEMBL1470144 | 0.82 | LMNA (0.50) | ALDH1A1TDP1 | |
| SCHEMBL377540 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL1470149 | 0.80 | LMNA (0.51) | ALDH1A1 | |
| SCHEMBL7574666 | 0.80 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL37366 | 0.79 | NAAA (0.62) | ALDH1A1NAAATSHRTP53CYP3A4 | |
| SCHEMBL21291971 | 0.79 | SMN1; SMN2 (0.39) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL26906538 | 0.79 | TSHR (0.58) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130295381-A1 | LATENT HARDENER WITH IMPROVED BARRIER PROPERTIES AND COMPATIBILITY | TRILLION SCIENCE, INC. | 2013-11-07 | — | — | US | claimed |
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | claimed |
| US-20120007259-A1 | LATENT HARDENER WITH IMPROVED BARRIER PROPERTIES AND COMPATIBILITY | TRILLION SCIENCE, INC. (US) | 2012-01-12 | — | — | US | claimed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | claimed |
| US-8044154-B2 | Latent hardener for epoxy compositions | TRILLION SCIENCE, INC. (US) | 2011-10-25 | — | — | US | claimed |
| US-20110220401-A1 | LATENT HARDENER WITH IMPROVED BARRIER PROPERTIES AND COMPATIBILITY | TRILLION SCIENCE, INC. (US) | 2011-09-15 | — | — | US | claimed |
| JP-2011509340-A | — | — | 2011-03-24 | — | — | JP | claimed |
| US-20100317545-A1 | LATENT HARDENER FOR EPOXY COMPOSITIONS | POLAROID B.V. (NL) | 2010-12-16 | — | — | US | claimed |
| WO-2010144236-A1 | LATENT HARDENER FOR EPOXY COMPOSITIONS | TRILLION SCIENCE, INC. (US) | 2010-12-16 | — | — | WO | claimed |
| WO-2009089314-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | WO | claimed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | claimed |
| US-10370557-B2 | D1563 radiation curable secondary coating for optical fibers | DSM IP ASSETS B.V. (NL) | 2019-08-06 | — | — | US | disclosed |
| US-20170355874-A1 | D1563 RADIATION CURABLE SECONDARY COATING FOR OPTICAL FIBERS | COVESTRO (NETHERLANDS) B.V. (NL) | 2017-12-14 | — | — | US | disclosed |
| WO-2016080829-A1 | D1563 RADIATION CURABLE SECONDARY COATING FOR OPTICAL FIBERS | DSM IP ASSETS B.V. (NL) | 2016-05-26 | — | — | WO | disclosed |
| US-20130295381-A1 | LATENT HARDENER WITH IMPROVED BARRIER PROPERTIES AND COMPATIBILITY | TRILLION SCIENCE, INC. | 2013-11-07 | — | — | US | disclosed |
| US-20110220401-A1 | LATENT HARDENER WITH IMPROVED BARRIER PROPERTIES AND COMPATIBILITY | TRILLION SCIENCE, INC. (US) | 2011-09-15 | — | — | US | disclosed |
| US-20100317545-A1 | LATENT HARDENER FOR EPOXY COMPOSITIONS | POLAROID B.V. (NL) | 2010-12-16 | — | — | US | disclosed |
| WO-2010144236-A1 | LATENT HARDENER FOR EPOXY COMPOSITIONS | TRILLION SCIENCE, INC. (US) | 2010-12-16 | — | — | WO | disclosed |
| WO-2009089314-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | RBX1, SUZ12, CDH1 | ALDH1A1 429/4885TDP1 620/4885SMN1; SMN2 1884/4885 |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | RBX1, SUZ12, CDH1 | ALDH1A1 429/4885TDP1 620/4885SMN1; SMN2 1884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.